Latest Conference Articles

ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters

Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial

Glaucoma genetics research can define the molecular basis of glaucoma and targets for developing curative or even preventive therapies, and it also pro-vides a basis for diagnostic and screening tests.

While MIGS has forever changed the surgical management of glaucoma, the space continues to evolve.

ICYMI: Here's what's in the 2019 pipeline

ICYMI: Dr. Packer shares the pearls from his 2019 ASCRS presentation 

Beyond the sessions, this year’s conference offers multiple events for attendees.

ICYMI: Frank W. Bowden, III, MD, FACS shares the take-home message from his 2019 ASCRS presentation. Check it out below!

Eva Liang, MD, discusses the take-home message from her presentation at ASCRS 2019

ICMYI: Dr. Tyson shares his pearls using the dexamethasone 0.4 mg insert (Dextenza, Ocular Therapeutix).

ICYMI: Dr. Shultz shares the results from a study comparing dual linear venturi phacoemulsification with adaptive fluidics systems using femtosecond-assisted grid pattern versus traditional phaco with horizontal chop

Robert Maloney, MD, shares how a novel system can assist refractive surgeons

Bausch + Lomb provides a company update at the 2019 ASCRS meeting. 

Here's why John Sheppard, MD, believes nutrition should be the cornerstone of dry eye therapy.

When used in supplement with other dry eye treatments, patients see improvement

Here's the latest innovations at Neurotech Pharmaceuticals, Inc. 

Selective laser trabeculoplasty (SLT) could be an affordable option for glaucoma management, according to Nathan Radcliffe, MD. 

Dr Jacqueline Beltz, FRANZCO, shares the take-home message from her 2019 ASCRS presentation

Topical drug for the treatment of dry eye disease sees potential 

E. Randy Craven, MD, shares results from a phase 1/2 study involving an intracameral bimatoprost sustained-release implant. 

Laura M. Periman, MD, shares how IPL therapy can quickly rid patients of painful chalazions

Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment 

Retina specialist Ron M. Kurtz, MD, details the way collaborative innovation can improve the lives of ophthalmic surgeons, and their patients.

Patients prefer the convenience of using a compounded triple combination drop over a standard medication plan.

Procedure may be a promising option for presbyopia correction in emmetropic patients, according to results of clinical trial presented by Aylin Kiliç, MD, at ASCRS 2019.